Best 10 oncology tests Factory in China 2025

Introduction to Oncology Tests

Oncology tests play a crucial role in the field of cancer diagnosis, treatment, and prognosis. These tests are designed to detect the presence of cancer cells, identify specific genetic mutations, and monitor the progression of the disease. They can range from traditional laboratory - based assays such as immunohistochemistry and in - situ hybridization to more advanced techniques like next - generation sequencing (NGS) and liquid biopsy. By providing accurate and detailed information about the cancer, oncology tests help doctors make more informed treatment decisions, select the most appropriate therapies, and predict patient outcomes. In recent years, the oncology testing market in China has witnessed significant growth, driven by factors such as the increasing incidence of cancer, the demand for personalized medicine, and the advancement of technology. Here are the top 10 oncology test factories in China in 2025.

1. Hangzhou Biotest Biotech Co., Ltd.

Hangzhou Biotest Biotech Co., Ltd. is a leading player in the oncology testing industry in China. The company is committed to the research, development, production, and sales of in - vitro diagnostic reagents and instruments. With a strong focus on oncology, Biotest Biotech has developed a series of high - quality testing products that are widely used in hospitals, clinics, and research institutions.

Features in Oncology Tests:

• Diverse Product Portfolio: Biotest Biotech offers a wide range of oncology tests, including immunohistochemistry kits, fluorescent in - situ hybridization (FISH) probes, and polymerase chain reaction (PCR) reagents. These products cover various aspects of cancer diagnosis, such as the detection of tumor markers, the identification of genetic mutations, and the assessment of tumor heterogeneity.
• High - Quality Standards: The company adheres to strict quality control measures throughout the production process. All products are developed and manufactured in accordance with international standards, ensuring high accuracy, sensitivity, and specificity. This has earned Biotest Biotech a good reputation in the market and the trust of customers.
• Continuous Innovation: Biotest Biotech invests heavily in research and development to keep up with the latest trends in oncology testing. The company has a professional R & D team that is constantly exploring new technologies and developing new products to meet the evolving needs of the market.

Advantages:

• Strong Technical Support: The company has a team of experienced technical experts who can provide comprehensive technical support to customers. Whether it is product installation, training, or troubleshooting, Biotest Biotech's technical team can offer timely and effective solutions.
• Good Customer Service: Biotest Biotech values customer satisfaction and provides excellent customer service. The company has a dedicated customer service department that can respond to customer inquiries and complaints promptly, ensuring a smooth and pleasant purchasing experience for customers.
• Competitive Pricing: Despite offering high - quality products, Biotest Biotech maintains competitive pricing. This makes its products more accessible to a wider range of customers, including those in developing regions.

Website: https://www.biotestrt.com/

2. BGI Genomics Co., Ltd.

BGI Genomics is a well - known genomics company in China. It has a global presence and is actively involved in various fields of genomics research, including oncology. The company was founded with the mission of using genomics to improve human health.

Features in Oncology Tests:

• Next - Generation Sequencing (NGS) Technology: BGI Genomics is at the forefront of NGS technology in oncology testing. It can perform large - scale sequencing of cancer genomes, enabling the detection of a wide range of genetic mutations, including single - nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations. This comprehensive analysis helps doctors understand the genetic landscape of the tumor and select the most appropriate targeted therapies.
• Multi - Omics Approach: In addition to genomics, BGI Genomics also incorporates transcriptomics, proteomics, and metabolomics into its oncology testing services. This multi - omics approach provides a more comprehensive view of the tumor biology, allowing for a more accurate diagnosis and prognosis.
• Large - Scale Data Resources: The company has built a large - scale genomics database through its extensive research projects. This database can be used for comparative analysis, which helps in identifying novel biomarkers and understanding the genetic basis of cancer across different populations.

Advantages:

• Global Research Network: BGI Genomics has established partnerships with research institutions and hospitals around the world. This global research network allows the company to access the latest research findings and collaborate on large - scale clinical trials, which in turn benefits its oncology testing services.
• Advanced Technology Platforms: The company has invested heavily in building advanced technology platforms for genomics research and testing. These platforms ensure high - throughput, accurate, and cost - effective sequencing, making it possible to offer competitive pricing for its oncology testing services.
• Skilled Workforce: BGI Genomics has a large team of highly skilled scientists, bioinformatics experts, and technicians. Their expertise in genomics research and oncology testing enables the company to provide high - quality services and develop innovative products.

3. Burning Rock Biotech Limited

Burning Rock Biotech is a pioneer in the field of liquid biopsy for oncology testing in China. The company focuses on developing and commercializing non - invasive cancer detection and monitoring technologies.

Features in Oncology Tests:

• Liquid Biopsy Technology: Burning Rock Biotech's core technology is liquid biopsy, which involves the analysis of circulating tumor DNA (ctDNA) and other biomarkers in the blood. This non - invasive approach allows for real - time monitoring of tumor progression, detection of minimal residual disease, and early cancer screening.
• High - Sensitivity Detection: The company has developed highly sensitive detection methods for ctDNA. These methods can detect low - level mutations in the blood, even in the early stages of cancer, which is crucial for early diagnosis and treatment.
• Clinical Validation: Burning Rock Biotech has conducted extensive clinical trials to validate the performance of its liquid biopsy tests. The results of these trials have demonstrated the high accuracy and clinical utility of its products, which have been widely recognized in the medical community.

Advantages:

• Early - Stage Focus: By focusing on early - stage cancer detection, Burning Rock Biotech can potentially improve patient outcomes by enabling earlier treatment. This is a significant advantage in the fight against cancer, as early - stage cancers are generally more treatable.
• Rapid Turnaround Time: The company has optimized its testing process to achieve a rapid turnaround time. This means that doctors can receive test results quickly, allowing for timely treatment decisions.
• Collaboration with Pharmaceutical Companies: Burning Rock Biotech has established partnerships with many pharmaceutical companies. These collaborations help in the development of companion diagnostics for new cancer drugs, which is beneficial for both the company and the pharmaceutical industry.

4. Nanjing GenScript Biotech Corporation

GenScript is a leading biotechnology company that offers a wide range of products and services, including oncology testing. The company has a strong R & D capability and is committed to providing high - quality biological reagents and testing solutions.

Features in Oncology Tests:

• Customized Assay Development: GenScript can develop customized oncology assays according to the specific needs of customers. Whether it is a new biomarker discovery or a specific genetic mutation detection, the company can design and optimize assays to meet the requirements.
• Protein - Based Assays: In addition to genetic testing, GenScript also offers protein - based oncology assays. These assays can detect the expression levels of various proteins in tumors, which is important for understanding the tumor microenvironment and the mechanism of cancer progression.
• Quality - Controlled Production: The company has a strict quality control system in place for the production of its oncology testing products. All products are tested for quality before being released to the market, ensuring reliable and reproducible results.

Advantages:

• One - Stop Solution: GenScript provides a one - stop solution for oncology testing, including reagent production, assay development, and data analysis. This convenience saves time and resources for customers.
• Global Distribution Network: The company has a global distribution network, which allows its oncology testing products to reach customers around the world. This wide market coverage enhances the company's competitiveness.
• Strong Intellectual Property Portfolio: GenScript has a large number of patents and intellectual property rights related to its oncology testing technologies. This provides a competitive edge in the market and protects the company's innovation.

5. Guangzhou Hybribio Limited

Hybribio is a well - established company in the field of in - vitro diagnostics, with a particular focus on oncology testing. The company has a long - standing history of developing and manufacturing high - quality diagnostic reagents.

Features in Oncology Tests:

• Immunodiagnostic Products: Hybribio specializes in the development of immunodiagnostic products for oncology. These products use antibodies to detect tumor - associated antigens, which are markers of cancer cells. The company's immunodiagnostic assays are known for their high sensitivity and specificity.
• Automated Testing Systems: Hybribio has developed automated testing systems for oncology testing. These systems can perform multiple tests simultaneously, improving the efficiency and accuracy of the testing process.
• Product Diversification: In addition to immunodiagnostic products, the company also offers other oncology testing products, such as nucleic acid detection kits. This product diversification allows the company to meet the different needs of customers.

Advantages:

• Long - Term Experience: With many years of experience in the in - vitro diagnostics industry, Hybribio has accumulated a wealth of knowledge and expertise in oncology testing. This experience enables the company to develop reliable and high - performance products.
• Local Market Advantage: As a Chinese company, Hybribio has a better understanding of the local market and the specific needs of Chinese customers. This allows the company to tailor its products and services to the local market, which is an important advantage in the domestic oncology testing market.
• Good After - Sales Service: Hybribio provides good after - sales service to its customers. The company offers technical support, training, and maintenance services, ensuring that customers can use its products effectively.

6. Shanghai Biochip Co., Ltd.

Shanghai Biochip is a company that focuses on the development and application of biochip technology in oncology testing. Biochips are miniaturized devices that can perform multiple biological assays simultaneously.

Features in Oncology Tests:

• Biochip - Based Assays: The company has developed a variety of biochip - based oncology assays. These assays can detect multiple biomarkers at the same time, providing a comprehensive profile of the tumor. This multi - biomarker analysis is more informative than single - biomarker tests and can help in more accurate cancer diagnosis and prognosis.
• High - Throughput Analysis: Biochips allow for high - throughput analysis, which means that a large number of samples can be tested in a short period of time. This is particularly useful for large - scale clinical studies and population - based screening programs.
• Customizable Biochips: Shanghai Biochip can customize biochips according to the specific requirements of customers. This flexibility allows for the development of personalized oncology testing solutions.

Advantages:

• Advanced Biochip Technology: The company has made significant progress in biochip technology research and development. Its biochips have high sensitivity, specificity, and reproducibility, making them suitable for a wide range of oncology testing applications.
• Collaboration with Research Institutions: Shanghai Biochip has established collaborations with many research institutions in China. These collaborations help in the translation of research findings into practical oncology testing products, and also promote the development of biochip technology in the field of oncology.
• Potential for Point - of - Care Testing: The miniaturized and high - throughput nature of biochips makes them suitable for point - of - care testing. Shanghai Biochip is exploring the potential of its biochip technology for on - site cancer diagnosis, which could improve the accessibility of oncology testing.

7. Wuhan MGI Tech Co., Ltd.

MGI Tech is a leading provider of high - throughput sequencing systems and related products for oncology testing. The company is committed to making genomics more accessible and affordable.

Features in Oncology Tests:

• High - Throughput Sequencing Platforms: MGI Tech's sequencing platforms can perform large - scale sequencing of cancer genomes with high accuracy and efficiency. These platforms can handle a large number of samples simultaneously, which is suitable for large - scale research projects and clinical testing.
• Cost - Effective Sequencing: The company has developed cost - effective sequencing technologies, which have significantly reduced the cost of oncology testing. This makes genomics - based oncology testing more accessible to a wider range of patients and research institutions.
• Complete Sequencing Solutions: MGI Tech provides complete sequencing solutions for oncology, including sample preparation, sequencing, and data analysis. This one - stop service simplifies the oncology testing process for customers.

Advantages:

• Independent Technology Development: MGI Tech has an independent R & D team and has developed its own core sequencing technologies. This independence in technology development gives the company more flexibility in product innovation and cost control.
• Global Market Expansion: The company has been actively expanding its global market. Its products have been widely used in many countries and regions, which has enhanced its brand awareness and competitiveness in the international oncology testing market.
• Technical Support and Training: MGI Tech offers comprehensive technical support and training services to its customers. This ensures that customers can operate its sequencing platforms effectively and obtain accurate test results.

8. Beijing Hotgen Biotech Co., Ltd.

Hotgen Biotech is a company that specializes in the development and production of molecular diagnostic products for oncology testing. The company focuses on the detection of genetic mutations and other molecular changes in cancer.

Features in Oncology Tests:

• Multiplex PCR Technology: Hotgen Biotech has developed multiplex PCR technology for oncology testing. This technology allows for the simultaneous detection of multiple genetic mutations in a single reaction, which is more efficient and cost - effective than traditional single - target PCR methods.
• High - Resolution Melting Analysis: The company also uses high - resolution melting analysis (HRMA) for mutation detection. HRMA is a sensitive and specific method that can detect small genetic variations, making it suitable for the detection of low - frequency mutations in cancer.
• Clinical - Grade Products: Hotgen Biotech's oncology testing products are designed to meet clinical - grade standards. They have been validated in clinical trials and are widely used in hospitals and clinics for cancer diagnosis and treatment monitoring.

Advantages:

• Rapid Product Development Cycle: The company has a rapid product development cycle, which allows it to quickly respond to the market demand for new oncology testing products. This is an important advantage in the fast - evolving field of oncology.
• Customer - Oriented Service: Hotgen Biotech provides customer - oriented service. The company can customize testing solutions according to the specific needs of customers, and also offers technical support and training to ensure the proper use of its products.
• Quality Assurance: The company has a strict quality assurance system in place. All products are subjected to rigorous quality control before being released to the market, ensuring the reliability and accuracy of the test results.

9. Suzhou Abogen Biosciences Co., Ltd.

Abogen Biosciences is a company that is actively involved in the development of mRNA - based technologies for oncology testing and treatment. mRNA technology has shown great potential in the field of oncology.

Features in Oncology Tests:

• mRNA - Based Biomarker Detection: Abogen Biosciences is exploring the use of mRNA as biomarkers for oncology testing. mRNA can provide information about the gene expression profile of the tumor, which is important for understanding the tumor biology and predicting the response to treatment.
• mRNA Vaccines for Cancer: In addition to testing, the company is also involved in the development of mRNA vaccines for cancer. These vaccines can stimulate the immune system to recognize and attack cancer cells, which is a promising approach for cancer treatment.
• Advanced mRNA Technology Platform: The company has built an advanced mRNA technology platform, which allows for the efficient production and delivery of mRNA molecules. This platform ensures the stability and efficacy of the mRNA - based products.

Advantages:

• Innovative Technology: The use of mRNA technology in oncology testing and treatment is an innovative approach. Abogen Biosciences' focus on this area gives it a competitive edge in the market, as it is at the forefront of a new and promising field.
• Research and Development Strength: The company has a strong R & D team that is dedicated to the research and development of mRNA - based technologies. This R & D strength enables the company to continuously innovate and develop new products.
• Collaboration with Research Institutions: Abogen Biosciences has established collaborations with many research institutions and universities. These collaborations help in the translation of basic research findings into practical oncology products and also promote the development of mRNA technology in the field of oncology.

10. Shenzhen Mindray Bio - Medical Electronics Co., Ltd.

Mindray is a well - known company in the medical device industry, and it also has a presence in the oncology testing field. The company offers a range of diagnostic products and solutions for oncology.

Features in Oncology Tests:

• Integrated Diagnostic Solutions: Mindray provides integrated diagnostic solutions for oncology, which include imaging equipment, laboratory testing instruments, and software for data analysis. This integration allows for a more comprehensive and efficient oncology diagnosis process.
• Advanced Imaging Technology: The company's imaging equipment, such as CT scanners and MRI machines, can provide high - resolution images of tumors. These images are important for tumor detection, staging, and treatment planning.
• Automated Laboratory Testing: Mindray's laboratory testing instruments are highly automated, which can improve the efficiency and accuracy of oncology testing. These instruments can perform a variety of tests, including blood tests and tissue analysis.

Advantages:

• Brand Reputation: Mindray has a strong brand reputation in the medical device industry. Its products are known for their high quality, reliability, and performance. This brand reputation gives customers confidence in using its oncology testing products.
• Global Service Network: The company has a global service network, which can provide timely technical support and maintenance services to customers around the world. This is an important advantage for customers who need reliable after - sales service.
• Continuous Innovation: Mindray is committed to continuous innovation. The company invests heavily in research and development to improve its oncology testing products and develop new technologies to meet the changing needs of the market.

Conclusion

The oncology testing industry in China is experiencing rapid growth, and the 10 companies mentioned above are at the forefront of this development. Each company has its own unique features and advantages in oncology testing, whether it is through advanced technology, innovative products, or excellent customer service. Hangzhou Biotest Biotech Co., Ltd. offers a diverse range of high - quality oncology testing products with strong technical support. BGI Genomics leads in NGS technology and multi - omics approach, while Burning Rock Biotech is a pioneer in liquid biopsy. Nanjing GenScript Biotech Corporation provides customized assay development, and Guangzhou Hybribio Limited specializes in immunodiagnostic products. Shanghai Biochip Co., Ltd. focuses on biochip - based assays, and Wuhan MGI Tech Co., Ltd. offers high - throughput sequencing solutions. Beijing Hotgen Biotech Co., Ltd. uses multiplex PCR and HRMA for mutation detection, Suzhou Abogen Biosciences explores mRNA - based technologies, and Shenzhen Mindray Bio - Medical Electronics Co., Ltd. provides integrated diagnostic solutions. These companies are not only contributing to the improvement of cancer diagnosis and treatment in China but also have the potential to make a significant impact on the global oncology testing market. As technology continues to advance and the demand for personalized medicine grows, these companies are likely to play an even more important role in the future of oncology.